TLDR
Prenetics purchased 100 Bitcoin tokens on October 31, 2025 for approximately $109,594 per coin.
The company now holds 378 BTC worth around $41 million in total value.
Prenetics completed a $44 million oversubscribed equity raise on October 28, 2025.
The health science firm maintains $127 million in total liquidity with zero debt.
Prenetics first entered the Bitcoin treasury market in June 2025 with a $20 million purchase.
Prenetics acquired 100 Bitcoin (BTC) tokens on October 31, 2025, expanding its digital asset holdings. The health science company backed by David Beckham paid approximately $109,594 per Bitcoin. Prenetics now holds 378 BTC worth around $41 million in total value.
Prenetics Strengthens Balance Sheet After Equity Raise
The Nasdaq-listed company completed a $44 million equity raise on October 28, 2025. The offering attracted strong investor interest and closed as an oversubscribed deal. Prenetics now maintains over $127 million in total liquidity across its balance sheet.
The company holds approximately $86 million in cash reserves alongside its bitcoin holdings. Prenetics currently carries no debt on its balance sheet. This financial position provides substantial resources for executing growth initiatives and treasury acquisitions.
Chief Executive Officer Danny Yeung emphasized the company’s execution speed following the capital raise.
“This 100 Bitcoin acquisition demonstrates our immediate execution on the strategic vision,” Yeung said.
He highlighted the company’s strong financial position with $127 million in liquidity.
Company Balances Supplement Growth With Crypto
Prenetics initiated its bitcoin treasury strategy with a $20 million purchase in June 2025. The company follows a systematic approach of acquiring one bitcoin daily. Prenetics also targets larger strategic purchases during favorable market conditions.
The health science firm plans to maintain this dual acquisition approach going forward. Management views the bitcoin treasury as a long-term value creation strategy. Prenetics aims to build substantial treasury assets while funding operational growth.
The company’s IM8 supplement brand generates $100 million in annual recurring revenue. Prenetics projects IM8 revenues between $180 million and $200 million for fiscal year 2026. This business segment represents a key growth driver for the company.
Yeung stated that Prenetics possesses sufficient capital for both operational and treasury objectives.
“We now have all the capital we need to maintain IM8’s market leadership,” he said.
The strategy balances supplement business expansion with Bitcoin accumulation activities.
Prenetics joined the corporate Bitcoin treasury trend alongside other publicly traded companies. The company executes purchases based on market timing and strategic considerations. Prenetics continues to evaluate price movements for optimal entry points on larger acquisitions.





Be the first to comment